SSStephen R. Spindler

Stephen R. Spindler

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Stephen R. Spindler has a total of 5 co-authors. Here are the top co-authors by number of shared publications:

  • Joseph M. Dhahbi

    BioMarker Pharmaceuticals, Incorporated, 900 East Hamilton Avenue, Campbell, CA 95008, USA

    2 shared publications
  • Patricia L. Mote

    BioMarker Pharmaceuticals, Incorporated, 900 East Hamilton Avenue, Campbell, CA 95008; and Departments of †Biochemistry and §Statistics, University of California, Riverside, CA 92521

    2 shared publications
  • Hyon-Jeen Kim

    BioMarker Pharmaceuticals, Incorporated, 900 East Hamilton Avenue, Campbell, CA 95008; and Departments of †Biochemistry and §Statistics, University of California, Riverside, CA 92521

    1 shared publication
  • Robert J. Beaver

    BioMarker Pharmaceuticals, Incorporated, 900 East Hamilton Avenue, Campbell, CA 95008; and Departments of †Biochemistry and §Statistics, University of California, Riverside, CA 92521

    1 shared publication
  • Shelley X. Cao

    Department of Biochemistry, University of California, Riverside, CA 92521, USA

    1 shared publication

Latest Publications

  • Temporal linkage between the phenotypic and genomic responses to caloric restriction

    by Joseph M. Dhahbi, Hyon-Jeen Kim, Patricia L. Mote, Robert J. Beaver, Stephen R. Spindler

    Caloric restriction (CR), the consumption of fewer calories while avoiding malnutrition, decelerates the rate of aging and the development of age-related diseases. CR has been viewed as less effective in older animals and as acting incrementally to slow or prevent age-related changes in gene expression. Here we demonstrate that CR initiated in 19-month-old mice begins within 2 months to increase the mean time to death by 42% and increase mean and maximum lifespans by 4.7 ( P = 0.000017) and 6.0 months ( P = 0.000056), respectively. The rate of age-associated mortality was decreased 3.1-fold. Between the first and second breakpoints in the CR survival curve (between 21 and 31 months of age), tumors as a cause of death decreased from 80% to 67% ( P = 0.012). Genome-wide microarray analysis of hepatic RNA from old control mice switched to CR for 2, 4, and 8 weeks showed a rapid and progressive shift toward the gene expression profile produced by long-term CR. This shift took place in the time frame required to induce the health and longevity effects of CR. Shifting from long-term CR to a control diet, which returns animals to the control rate of aging, reversed 90% of the gene expression effects of long-term CR within 8 weeks. These results suggest a cause-and-effect relationship between the rate of aging and the CR-associated gene expression biomarkers. Therefore, therapeutics mimicking the gene-expression biomarkers of CR may reproduce its physiological effects.


  • Genomic profiling of short- and long-term caloric restriction effects in the liver of aging mice

    by Shelley X. Cao, Joseph M. Dhahbi, Patricia L. Mote, Stephen R. Spindler

    We present genome-wide microarray expression analysis of 11,000 genes in an aging potentially mitotic tissue, the liver. This organ has a major impact on health and homeostasis during aging. The effects of life- and health-span-extending caloric restriction (CR) on gene expression among young and old mice and between long-term CR (LT-CR) and short-term CR (ST-CR) were examined. This experimental design allowed us to accurately distinguish the effects of aging from those of CR on gene expression. Aging was accompanied by changes in gene expression associated with increased inflammation, cellular stress, and fibrosis, and reduced capacity for apoptosis, xenobiotic metabolism, normal cell-cycling, and DNA replication. LT-CR and just 4 weeks of ST-CR reversed the majority of these changes. LT-CR produced in young mice a pattern of gene expression that is a subset of the changes found in old LT-CR mice. It is possible that the early changes in gene expression, which extend into old age, are key to the life- and health-span-extending effects of CR. Further, ST-CR substantially shifted the “normo-aging” genomic profile of old control mice toward the “slow-aging” profile associated with LT-CR. Therefore, many of the genomic effects of CR are established rapidly. Thus, expression profiling should prove useful in quickly identifying CR- mimetic drugs and treatments.


  • Open Access

    Reversing the Negative Genomic Effects of Aging with Short-Term Calorie Restriction

    by Stephen R. Spindler

    According to government figures, total health care spending in the U.S. in 1999 was $1.316 trillion. The government projects an increase in health care costs to $2.176 trillion by 2008. If we project this growth rate to 2020, health care costs will reach $4.009 trillion. Today, people often spend more health care dollars during the last year of their lives than in all previous years combined. Medical treatment in the last few years of life is usually very expensive and often futile. With the baby-boom generation now moving through middle age, the prescription for the U.S. health care system will be disastrous unless we learn how to keep people healthier longer. This dramatic increase in health care costs leaves us with only one acceptable alternative to rationed health care or financial ruin — to discover interventions that make people functionally younger, healthier, and less susceptible to debilitating, age-related diseases.